Skip to content

Study · Not a test of the peptide alone · 2003

1 result

Immediate and residual effects of tamoxifen and ethynylestradiol in the female rat hypothalamus.

Patisaul HB, Aultman EA, Bielsky IF, Young LJ, Wilson ME

Brain research1 Jul 2003Cited by 19 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01AnimalNot a test of Oxytocin aloneAnimal study (in vivo)Mechanism

    In ovariectomized female rats not given estrogen, tamoxifen and ethynylestradiol increased oxytocin receptor binding in the ventromedial nucleus of the hypothalamus.

    In plain wordsIn female rats, tamoxifen and a synthetic estrogen increased oxytocin receptor binding in a brain region; oxytocin itself was not given.

    Peptide
    Oxytocin
    Outcome
    IncreaseOxytocin receptor binding in the ventromedial hypothalamus
    Study

    ratn: not reported in source

    ovariectomized female rats
    Comparator
    Sesame oil
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    TAMOX and EE increased oxytocin receptor binding in the ventromedial nucleus of the hypothalamus (VMN) in the absence of estrogen in both groups 1 and 2.
    1 context sentence
    Summary · context
    Two groups of adult, ovariectomized, female rats (n=30 per group) were injected with TAMOX (5 mg/kg), EE (0.1 mg/kg), or sesame oil daily for 14 days.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.